Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma
about
Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluationIdentification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma.A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patientsOAHG: an integrated resource for annotating human genes with multi-level ontologies.IntNetLncSim: an integrative network analysis method to infer human lncRNA functional similarity.Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.Construction of differential mRNA-lncRNA crosstalk networks based on ceRNA hypothesis uncover key roles of lncRNAs implicated in esophageal squamous cell carcinoma.A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.Relationship between LINC00341 expression and cancer prognosis.Microarray analysis reveals differentially expressed lncRNAs in benign epithelial ovarian cysts and normal ovaries.Annotating the Function of the Human Genome with Gene Ontology and Disease Ontology.Up-regulation of long non-coding RNA SPRY4-IT1 promotes tumor cell migration and invasion in lung adenocarcinoma.Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma.Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.Identification of long non-coding RNAs biomarkers for early diagnosis of myocardial infarction from the dysregulated coding-non-coding co-expression network.Analysis of long non-coding RNA expression profiles identifies novel lncRNA biomarkers in the tumorigenesis and malignant progression of gliomas.Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2A potential panel of two-long non-coding RNA signature to predict recurrence of patients with laryngeal cancer.Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.Identification of potential long non-coding RNA biomarkers associated with the progression of colon cancer.An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer.A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer.Measuring disease similarity and predicting disease-related ncRNAs by a novel method.Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma.Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma.A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.Analysis of long non-coding RNA expression profiles identifies functional lncRNAs associated with the progression of acute coronary syndromes.Identification of a progression-associated long non-coding RNA signature for predicting the prognosis of lung squamous cell carcinoma.Five key lncRNAs considered as prognostic targets for predicting Pancreatic Ductal Adenocarcinoma.Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma.An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer
P2860
Q33559988-C51849C1-BEEC-4ABD-BB41-89E374C880ACQ33919936-552EBC7E-E4E8-4C98-AE3B-C4AA6C5F5739Q36996542-BC985D19-03DF-465F-9DA4-6D528935E86FQ37159825-861F1A5D-183F-4D38-803A-F2702B3F00CEQ37310783-1CF0E82C-5CBC-4FB9-BC41-2B0A585F81E8Q37565302-86BE4C7A-79D0-4CEE-8A76-34481DA16A59Q37636634-0E97C555-2042-43D9-8583-2581C8AD8B61Q37699115-1580EBE1-6E80-493E-A770-C8BE41AB5486Q37716461-560CEAAD-5934-442F-9D6D-9A64A5D3C170Q37716538-73371EBC-FE0C-4E67-B98E-00A20378882BQ38431931-BF0C4CDA-F35E-41D8-8540-6BE38916C7DBQ38442724-348D8777-1547-4A6F-8DE3-54F96F4F7A16Q40062436-192ED6A2-5BEC-4FFF-B956-04A786B7D8C6Q40257510-E1C024F7-092E-461B-8C97-6ABC5C3A766AQ41233998-6340B32E-63CF-43A6-8291-BBAC6A2F880EQ41592648-3C6D4888-9E8F-4B81-A14F-6B95B68E37ACQ41592814-78AD6744-64B6-4B53-A8E0-8B426D2A631BQ41709267-BFC4B8BC-07BC-41C8-8989-C46A690784F7Q42078197-524D8037-824F-4720-BDF9-0FBC51B35D4FQ42128391-0E1D6307-DBB5-4261-A859-338095DA4F27Q42317549-5802C8F6-4B5D-4BCB-9FD8-ED1CFB7544CBQ42366572-351032D2-3181-49FE-AB26-6A09C38D1C09Q42366627-1B04B5B0-53EB-41AF-A433-FD88EB69CD65Q42378366-10ECC6DC-FC53-4410-898A-A67D3CF8104FQ43451695-B4D11B69-E9F3-42FF-A0AE-3B0C541B5CADQ44279014-6606764C-90C0-4A60-AFBD-97A533A88C15Q47095221-B26E52E8-ED07-4B4B-8994-AF23B77C2141Q47137671-90B7E728-2B37-4C93-9161-D47F70FD6ABDQ47143921-057ACC03-1691-4729-BA0E-AC123B995AB9Q47148401-FC244B70-63F3-401C-83A2-4114D5C78AF1Q47155278-720F8D09-68F7-450E-917E-5F400BAE66C6Q47160779-AEE81A8F-9A64-4D15-8852-41F76DB2D7DAQ47204629-BAA64BC3-CDB7-470C-8710-BE280487ECA3Q49406445-C6E3CB5D-8B9A-4CCD-B290-405E1C94C2DBQ49591680-22D690AF-E9FA-4A2A-A307-5B2DF70796F7Q49852516-1C0FC757-929F-44A0-81A4-26F31E7CAF11Q52372086-7EB1B73C-8ACB-433B-89C7-65EC464FE2EDQ54537800-697BA435-6A19-40EF-84BB-521548D7B02BQ58786413-AEBC2FFA-2B84-446E-B15B-969552CB4C91
P2860
Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relapse-related long non-codin ...... diction of lung adenocarcinoma
@en
Relapse-related long non-codin ...... iction of lung adenocarcinoma.
@nl
type
label
Relapse-related long non-codin ...... diction of lung adenocarcinoma
@en
Relapse-related long non-codin ...... iction of lung adenocarcinoma.
@nl
prefLabel
Relapse-related long non-codin ...... diction of lung adenocarcinoma
@en
Relapse-related long non-codin ...... iction of lung adenocarcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Relapse-related long non-codin ...... diction of lung adenocarcinoma
@en
P2093
Hengqiang Zhao
Hongbo Shi
Wanying Xu
Xiaolong Yue
Zhenzhen Wang
P2860
P304
29720-29738
P356
10.18632/ONCOTARGET.8825
P407
P577
2016-04-18T00:00:00Z